对于半面的A型肉毒素治疗后影响短期预后的因素:一项回顾性研究
Sheng Tian1, Heqing Zheng1, Lanxiang Wu1
1Department of Neurology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, China.
Heliyon
|February 5, 2024
概括
毒素A型有效治疗半面 (HFS). 然而,高血压是接受这种治疗的HFS患者短期预后不佳的重要风险因素.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 医疗治疗 医疗治疗
背景情况:
- 毒素A型 (BTX-A) 是对半面 (HFS) 的常见治疗方法.
- 影响BTX-A在HFS治疗疗效的因素需要系统分析.
- 识别不良预后的风险因素对于优化HFS管理至关重要.
研究的目的:
- 研究影响HFS患者BTX-A治疗结果的因素.
- 为了确定BTX-A治疗的HFS中短期预后不佳的预测因素.
主要方法:
- 一项回顾性研究分析了118名接受BTX-A治疗的HFS患者.
- 数据包括人口统计,病因,BTX-A剂量,疗程,注射肌肉和反应.
- 后勤回归确定了与短期预后相关的因素.
主要成果:
- 对于HFS,BTX-A的整体有效率为91.53%.
- 单变量分析将男性性别,酒精消费,糖尿病和高血压与较差的结果联系起来.
- 多变量分析确定高血压是短期预后不佳的独立风险因素 (OR=5.847,P<0.05).
结论:
- 在HFS治疗中,BTX-A显示出高效率和良好的安全性.
- 高血压是BTX-A.治疗的高血压患者中低于最佳的短期结果的重要独立风险因素.
相关概念视频
Skeletal Muscle Relaxants: Therapeutic Uses
487
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
487
Skeletal Muscle Relaxants: Adverse Effects
373
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
373
Depolarizing Blockers: Pharmocokinetics
327
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
327
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
682
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
682


